Vital role of FKBP51 signalling molecule in obesity
top of page
Browse by category
Search
Researchers from the University of Kentucky College of Medicine and the University of Toledo suggests a vital role for the signalling...
Journal watch - review of the latest clinical papers 06/10/2021
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Ketone supplement could aid brain function in people with obesity
Ketone supplements may be a novel therapeutic strategy for protecting and improving brain health in people with obesity, according to...
Bariatric surgery is safe and effective in patients with advanced liver disease
Non-alcoholic fatty liver disease (NAFLD) has been reported in approximately 70-90% of patients with morbid obesity undergoing metabolic...
Why fat cells cause metabolic morbidity
Swedish researchers at Karolinska Institutet have found further explanation for why fat cells cause metabolic morbidity. The study,...
COVID-19 may trigger hyperglycemia increasing morality
COVID-19 may bring high risks of severe disease and death in many patients by disrupting key metabolic signals and thereby triggering...
Antidepressant and antipsychotic drugs usage common before T2DM diagnosis
Almost three in ten people with type 2 diabetes (T2D) in Scotland were prescribed antidepressants before they were diagnosed with...
Low-carb diet improves cardiometabolic risk profile
A clinical trial led by Boston Children's Hospital has reported that low-carb diets - even though higher in saturated fat - produce...
Rare form of obesity named Blakemore-Durmaz-Vasileiou syndrome
A Brunel University London professor has joined the illustrious pantheon of Hans Asperger and John Langdon Down by having a syndrome...
Trial to assess diet composition to treat T2DM
A clinical trial now enrolling at the University of Alabama at Birmingham is taking an unusual approach to help patients with Type 2...
Browse by tag
bottom of page